- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04048681
Neurological Impacts of Artificial Sweeteners in the Context of Diet Sodas
January 22, 2020 updated by: Olivia Farr, Beth Israel Deaconess Medical Center
This study seeks to determine whether artificial sweeteners in the context of diet soda may alter the brain's response to food cues and thus impact appetite.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
5
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02215
- Beth Israel Deaconess Medical Center MRI Research Facility
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Men and women who are 18-65 years old, with a BMI >30kg/m2.
Exclusion Criteria:
- Unable or unwilling to participate in the study for any reason
- Metal in the body or other safety concerns which makes patient unable to have an MRI
- Pregnant women will be excluded to protect the fetus against potential effects of a non-medically required MRI on fetal development and difficulty of measuring accurate BMI.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: OTHER
- Allocation: RANDOMIZED
- Interventional Model: CROSSOVER
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Diet Soda
12oz can of Diet Coke
|
12 oz can of artificially sweetened cola beverage (Diet Coke planned to be used but similar to Diet Pepsi or other Diet Colas)
Other Names:
|
|
ACTIVE_COMPARATOR: Soda
12oz can of Coke
|
12oz can of regular cola beverage (Coke planned but similar to Pepsi or other regular cola sodas)
Other Names:
|
|
PLACEBO_COMPARATOR: Carbonated Water
12oz can of carbonated (unflavored) water
|
12oz can of carbonated water (sparking water, selzter water) unflavored
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in Brain Response to Food Cues in the Insula
Time Frame: 1 hour
|
Functional magnetic resonance imaging (BOLD signals) while patients view food vs. non-food cues.
The effect size z-score represents the magnitude of the activation in that area to food cues vs. non-food cues.
The z-score is the estimated response magnitude in that area compared to the overall mean.
Negative numbers indicate values lower than the mean and positive numbers indicate values above the mean.
|
1 hour
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Neurocognitive Testing (Stop Signal Reaction Time)
Time Frame: 1 hour
|
stop signal reaction time is a measure of inhibitory control, where a shorter stop signal reaction time indicates greater inhibitory control.
|
1 hour
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
August 6, 2019
Primary Completion (ACTUAL)
December 20, 2019
Study Completion (ACTUAL)
December 20, 2019
Study Registration Dates
First Submitted
August 6, 2019
First Submitted That Met QC Criteria
August 6, 2019
First Posted (ACTUAL)
August 7, 2019
Study Record Updates
Last Update Posted (ACTUAL)
February 5, 2020
Last Update Submitted That Met QC Criteria
January 22, 2020
Last Verified
January 1, 2020
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Physiological Effects of Drugs
- Neurotransmitter Agents
- Molecular Mechanisms of Pharmacological Action
- Central Nervous System Depressants
- Peripheral Nervous System Agents
- Sensory System Agents
- Anesthetics
- Neurotransmitter Uptake Inhibitors
- Membrane Transport Modulators
- Dopamine Agents
- Anesthetics, Local
- Dopamine Uptake Inhibitors
- Vasoconstrictor Agents
- Cocaine
Other Study ID Numbers
- 2019P000649
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
Data is HIPAA protected and will not be shared.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | Obesity and Obesity-related Medical ConditionsUnited States
-
Central Hospital, Nancy, FranceNot yet recruiting
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | GLP-1 | Obesity and Obesity-related Medical Conditions | Ablation TechniquesUnited States
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
Clinical Trials on diet soda
-
George Washington UniversityCompletedBreastfeedingUnited States
-
George Washington UniversityCompleted
-
George Washington UniversityCompletedObesity | Diabetes
-
National Institute of Diabetes and Digestive and...RecruitingHealthy Volunteers | Diet TherapyUnited States
-
Texas Christian UniversityCompletedOlipop | Poppi | Coca Cola - Classic | Diet CokeUnited States
-
Rockefeller UniversityCompletedGlucose Metabolism DisorderUnited States
-
University of ArkansasCompletedMuscle Weakness | Muscular AtrophyUnited States
-
Universidade do PortoCompleted
-
Olipop, PBCINQUIS Clinical ResearchRecruitingSatiety in Healthy VolunteersCanada
-
University of ArizonaCompleted